The Places We'll Go Marketing Show

The episode contains useful frameworks and real examples (Panadol's 'tough but gentle' positioning, the mouth-talking campaign, Voltaren segmentation to young athletes), but much of the runtime is devoted to career biography, soft leadership platitudes ('vision,' 'critical thinking,' 'people development'), and repetitive points about consumer-centricity and global vs. local trade-offs. Few genuinely novel claims about marketing practice emerge that a seasoned B2B operator wouldn't already know.

“we talk about being consumer first always”

“the art of great marketing is really good quality thinking up front”

Rogers recycles well-known frameworks (Byron Sharp on penetration, 'jobs to be done,' health literacy in regulated categories) without adding counterintuitive twists. The Panadol and Voltaren examples are sound but not particularly fresh. Her concern about AI making marketers passive thinkers is sensible but widely aired. No contrarian arguments or first-principles rethinking of category norms.

“the Byron Sharp model penetration and re, uh, winning your consumer back is the best way to think about building”

“what do they think and feel now? What do I need to think and feel differently?”

Rogers is genuinely credible: 25 years at Unilever, led the spinoff of a $10B consumer health company from GSK as CMO, architected organizational transformation. She has operated at significant scale and done real strategic work. However, she is somewhat cautious about sharing specifics ('I can't share at this point because it is, we are at the beginning of that change journey'), which slightly limits the practical utility of her experience for listeners.

“Tamara spent 25 years at Unilever, helped spin one of the world's biggest consumer health companies out of GSK”

“built a marketing function that put the consumer at the very heart of a $10 billion business”

Rogers provides some named examples (Panadol, Voltaren, Halion, GSK) and campaign details (the 'mouth talks' creative concept), but often retreats into generality when discussing strategy, transformation, and operating models. Numbers are sparse: she mentions 98% of the world can take Panadol, ~90% suffer pain, but avoids concrete metrics on business impact, growth rates, or campaign ROI. The Halian brand-building framework is described conceptually but not operationalized with data.

“Panadol is a wonderful brand”

“the idea then formed obviously with a combination of that insight from talking to dentists...if your mouth could talk, what would it tell you?”

The hosts ask soft, open-ended questions that allow Rogers to control the narrative. There is minimal push-back, few sharp follow-ups on vague claims, and no productive disagreement. When Rogers mentions AI concerns, the host validates rather than probes. Questions about org design, global vs. local, and CMO skills are broad and permissive rather than drilling into contradiction or testing assumptions. The conversation reads as a respectful interview rather than a working dialogue.

“Hey, Tamara. Fabulous to have you on the show.”

“Um, there's a bit of a worry here, really, when you think about it, because the will of AI, of course, is upon us”